Page last updated: 2024-09-04

olmesartan and Pericementitis

olmesartan has been researched along with Pericementitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Araújo, AA; de Castro Brito, GA; do Socorro Costa Feitosa Alves, M; Fernandes de Araújo, R; Lopes de Souza, G; Lourenço, Y; Sabóia Aragão, K; Souza, TO; Xavier de Medeiros, CA	1

Other Studies

1 other study(ies) available for olmesartan and Pericementitis

Article	Year
Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis. Naunyn-Schmiedeberg's archives of pharmacology, 2013, Volume: 386, Issue:10 Topics: Alveolar Bone Loss; Animals; Anti-Inflammatory Agents; Cyclooxygenase 2; Gingiva; Imidazoles; Interleukin-1beta; Male; Malondialdehyde; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Osteoprotegerin; Periodontitis; Peroxidase; RANK Ligand; Rats; Rats, Wistar; Receptor Activator of Nuclear Factor-kappa B; Tetrazoles; Tumor Necrosis Factor-alpha	2013

Article

Year

Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis.

Naunyn-Schmiedeberg's archives of pharmacology, 2013, Volume: 386, Issue:10

Topics: Alveolar Bone Loss; Animals; Anti-Inflammatory Agents; Cyclooxygenase 2; Gingiva; Imidazoles; Interleukin-1beta; Male; Malondialdehyde; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Osteoprotegerin; Periodontitis; Peroxidase; RANK Ligand; Rats; Rats, Wistar; Receptor Activator of Nuclear Factor-kappa B; Tetrazoles; Tumor Necrosis Factor-alpha

2013